Gene · 7473
Papers2,406
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,406
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PMAIP1 regulates the progression of follicular thyroid carcinoma through the Wnt3/FOSL1 pathway. | Front Oncol | 2025 | 39944827 | PubTator, text mining | PubMed |
| Defective DNA repair: a putative nexus linking immunological diseases, neurodegenerative disorders, and cancer. | Mutagenesis | 2025 | 39937585 | PubTator, text mining | PubMed |
| Organizer formation, organizer maintenance and epithelial cell plasticity in Hydra: Role of the Wnt3/β-catenin/TCF/Sp5/Zic4 gene network. | Cells Dev | 2025 | 39929422 | PubTator, text mining | PubMed |
| Identification of serum small non-coding RNA as biomarkers for endometrial receptivity. | Genomics | 2025 | 39848478 | PubTator, text mining | PubMed |
| MRPL24 drives breast cancer metastasis and stemness by targeting c-MYC, BRD4, and STAT3. | 3 Biotech | 2025 | 39802327 | PubTator, text mining | PubMed |
| Genome-wide epistasis analysis reveals significant epistatic signals associated with Parkinson's disease risk. | Brain | 2025 | 39657708 | PubTator, text mining | PubMed |
| Inhibition of CB1R in the Hypothalamic Paraventricular Nucleus Ameliorates Hypertension Through Wnt/β-Catenin/RAS Pathway. | Cardiovasc Toxicol | 2025 | 39467886 | PubTator, text mining | PubMed |
| Amyloid-β predominant Alzheimer's disease neuropathologic change. | Brain | 2025 | 39417691 | PubTator, text mining | PubMed |
| USP7 facilitates deubiquitination of LRRC42 in colorectal cancer to accelerate tumorigenesis and augment Wnt/β-catenin signaling. | Biochim Biophys Acta Mol Cell Res | 2025 | 39393471 | PubTator, text mining | PubMed |
| Oxidative DNA damage promotes vascular ageing associated with changes in extracellular matrix-regulating proteins. | Cardiovasc Res | 2025 | 38717632 | PubTator, text mining | PubMed |
| Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway. | J Adv Res | 2025 | 38432393 | PubTator, text mining | PubMed |
| Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo. | Hereditas | 2024 | 39605083 | PubTator, text mining | PubMed |
| Epithelial-mesenchymal crosstalk: the scriptwriter of craniofacial morphogenesis. | Front Cell Dev Biol | 2024 | 39583201 | PubTator, text mining | PubMed |
| Hyperbaric oxygen therapy as a neuromodulatory technique: a review of the recent evidence. | Front Neurol | 2024 | 39445195 | PubTator, text mining | PubMed |
| Genome-wide identification and expression profiling of the Wnt gene family in three abalone species. | Genes Genomics | 2024 | 39397130 | PubTator, text mining | PubMed |
| Causal effect of thyroid cancer on secondary primary malignancies: findings from the UK Biobank and FinnGen cohorts. | Front Immunol | 2024 | 39391305 | PubTator, text mining | PubMed |
| Alpha-1-antitrypsin improves anastomotic healing in intestinal epithelial cells model. | Pediatr Surg Int | 2024 | 39347946 | PubTator, text mining | PubMed |
| Comparative analysis of natural resistance-associated macrophage protein 1 gene expression and anti-PGL-1 antibodies in multibacillary leprosy and household contacts. | Trop Biomed | 2024 | 39154276 | PubTator, text mining | PubMed |
| ERK5 promotes autocrine expression to sustain mitogenic balance for cell fate specification in human pluripotent stem cells. | Stem Cell Reports | 2024 | 39151429 | PubTator, text mining | PubMed |
| Identification of Potential Drug Targets for Myopia Through Mendelian Randomization. | Invest Ophthalmol Vis Sci | 2024 | 39110588 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7473/papers?page=4